Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.64 |
| ▸ | CA12 | O43570 | 2/20 | 0.64 |
| ▸ | CA1 | P00915 | 2/20 | 0.64 |
| ▸ | CA2 | P00918 | 2/20 | 0.64 |
| ▸ | MAPT | P10636 | 2/20 | 0.64 |
| ▸ | CA4 | P22748 | 2/20 | 0.64 |
| ▸ | CA6 | P23280 | 2/20 | 0.64 |
| ▸ | CA7 | P43166 | 2/20 | 0.64 |
| ▸ | CA9 | Q16790 | 2/20 | 0.64 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.64 |
| ▸ | POLB | P06746 | 1/20 | 0.64 |
| ▸ | GAA | P10253 | 1/20 | 0.64 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.64 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.64 |
| ▸ | MYC | P01106 | 3/20 | 0.56 |
| ▸ | TSHR | P16473 | 3/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL71388 | 1.00 | KDM4E (0.64) | KDM4ECA12CA1CA2MAPT | |
| SCHEMBL1758255 | 0.84 | HTT (0.61) | MAPTPOLBTSHRHTTALDH1A1 | |
| Triethylene Glycol SCHEMBL11021539 | 0.83 | CA12 (0.46) | KDM4ECA12CA1CA2MAPT | |
| SCHEMBL29979976 | 0.82 | CA12 (0.64) | KDM4ECA12CA1CA2MAPT | |
| SCHEMBL1550819 | 0.82 | PKM (0.52) | MAPTPOLBGAATSHRHTT | |
| SCHEMBL172420 | 0.82 | CA12 (0.64) | KDM4ECA12CA1CA2MAPT | |
| SCHEMBL29421064 | 0.81 | CES2 (0.63) | KDM4ECA12CA1CA2MAPT | |
| SCHEMBL310259 | 0.81 | CES2 (0.63) | KDM4ECA12CA1CA2MAPT | |
| SCHEMBL4276908 | 0.80 | TRPA1 (0.47) | KDM4ECA12CA1CA2MAPT | |
| SCHEMBL1805871 | 0.80 | LCK (0.53) | KDM4ECA1CA2MAPTTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4712958-A2 | USE OF UROLITHIN DERIVATIVES IN THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS | Vandria SA (CH) | 2026-03-25 | — | — | EP | disclosed |
| EP-4630423-A1 | COMPOUNDS AND COMPOSITIONS AS C-KIT KINASE INHIBITORS | Third Harmonic Bio, Inc. (US) | 2025-10-15 | — | — | EP | disclosed |
| EP-4561976-A2 | UROLITHIN AND FLUORENE DERIVATIVES FOR INHIBITING FERROPTOSIS | Vandria SA (CH) | 2025-06-04 | — | — | EP | disclosed |
| WO-2025023241-A1 | ETCHING LIQUID AND PRODUCTION METHOD FOR SEMICONDUCTOR DEVICE USING SAME | 三菱瓦斯化学株式会社 | 2025-01-30 | — | — | WO | disclosed |
| WO-2024236367-A2 | USE OF UROLITHIN DERIVATIVES IN THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS | VANDRIA SA (CH) | 2024-11-21 | — | — | WO | disclosed |
| WO-2024123966-A1 | COMPOUNDS AND COMPOSITIONS AS C-KIT KINASE INHIBITORS | THIRD HARMONIC BIO, INC. (US) | 2024-06-13 | — | — | WO | disclosed |
| WO-2024023585-A2 | UROLITHIN DERIVATIVES AND THERAPEUTIC USES | VANDRIA SA (CH) | 2024-02-01 | — | — | WO | disclosed |
| WO-2022078152-A1 | BENZIMIDAZOLONE GLP-1 RECEPTOR AGONIST AND USE THEREOF | 杭州中美华东制药有限公司 | 2022-04-21 | — | — | WO | disclosed |